Kosten-Nutzen-Analysen bilden zunehmend die Basis für die öffentliche Finanzierung des Gesundheitssystems, wodurch der Nachweis von Therapieeffekten an Bedeutung gewinnt. In der logopädischen Therapieforschung fehlen vielfach Instrumente zur Erhebung der Therapieeffekte. Ziel dieser Studie war es zu überprüfen, ob das Konzept «Lebensqualität», erhoben mit der Münchner Lebensqualitätsdimensionen-Liste (MLDL), dazu geeignet ist. 25 erwachsene Patienten mit Schlafstörung wurden zu Beginn und am Ende einer logopädischen Therapie (zirka 20 h) mit der MLDL befragt. Obwohl der Grossteil der Patienten mit der Therapie sehr zufrieden war, zeigten nur 2 der 19 MLDL-Items eine signifikante Verbesserung an («Entspannungsfähigkeit», p < 0,05; «Behandlung der Stimmstörung», p < 0,01). Die MLDL ist zu wenig sensitiv für Effekte der logopädischen Intervention. Die Entwicklung spezieller Skalen für die logopädische Therapieforschung wird angeregt.

Keywords:
Logopedics, Munich List of Quality-of-Life Dimensions (MLDL), Quality of life, Therapy research, Voice disorders
This content is only available via PDF.
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.